AnaptysBio
ANAB
#4635
Rank
A$3.10 B
Marketcap
A$74.79
Share price
3.34%
Change (1 day)
121.00%
Change (1 year)

Earnings for AnaptysBio (ANAB)

Earnings in 2025 (TTM): A$97.67 Million

According to AnaptysBio's latest financial reports the company's current earnings are A$0.23 Billion. , an increase over its 2024 earnings that were of -A$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AnaptysBio from 2015 to 2025

Annual earnings

Year Earnings Change
2025 A$93.33 M-170.24%
2024 -A$0.14 Billion-34.63%
2023 -A$0.21 Billion35.27%
2022 -A$0.16 Billion92.31%
2021 -A$78.15 Million137.28%
2020 -A$32.94 Million-75.55%
2019 -A$0.14 Billion60.22%
2018 -A$84.08 Million112.74%
2017 -A$39.53 Million644.41%
2016 -A$5.31 Million-20.91%
2015 -A$6.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.21 Billion-321.51%๐Ÿ‡บ๐Ÿ‡ธ USA